Purpose To investigate whether radiomics features extracted from magnetic resonance
imaging (MRI) of patients with biopsy-proven atypical ductal hyperplasia (ADH) coupled with …

Purpose To evaluate the diagnostic value of dynamic contrast‐enhanced (DCE) magnetic
resonance imaging (MRI) for patients with atypical ductal hyperplasia (ADH) in predicting …

Background Atypical ductal hyperplasia diagnosed on percutaneous breast biopsy typically
undergoes surgical excision, upgrading to invasive breast cancer or ductal carcinoma in situ …

Background A malignancy might be found at surgery in cases of atypical ductal hyperplasia
(ADH) diagnosed via US-guided core needle biopsy (CNB). The objective of this study was …

Objective: To investigate whether support vector machine (SVM) trained with radiomics
features based on breast magnetic resonance imaging (MRI) could predict the upgrade of …

Purpose To evaluate the diagnostic performance of dynamic contrast-enhanced (DCE)–MRI
in predicting malignancy after percutaneous biopsy diagnosis of atypical ductal hyperplasia …

Introduction We previously developed a convolutional neural networks (CNN)-based
algorithm to distinguish atypical ductal hyperplasia (ADH) from ductal carcinoma in situ …

Purpose To identify breast MR imaging biomarkers to predict histologic grade and receptor
status of ductal carcinoma in situ (DCIS). Materials and Methods Informed consent was …

Aims Risk stratification of atypical ductal hyperplasia (ADH) and ductal carcinoma in situ
(DCIS), diagnosed using breast biopsy, has great clinical significance. Clinical trials are …

Background Risk assessment and therapeutic options are challenges when counselling
patients with an atypical ductal hyperplasia (ADH) to undergo either open surgery or follow …